189 related articles for article (PubMed ID: 23957982)
41. Outcome of Stevens Johnson syndrome and toxic epidermal necrolysis treated with corticosteroids.
Rijal A; Agrawal S
Indian J Dermatol Venereol Leprol; 2009; 75(6):613-4. PubMed ID: 19915248
[No Abstract] [Full Text] [Related]
42. The use of cyclosporine for Stevens-Johnson syndrome-toxic epidermal necrolysis spectrum at the University of Louisville: A case series and literature review.
Conner CD; McKenzie E; Owen CE; Callen JP
Dermatol Online J; 2018 Jan; 24(1):. PubMed ID: 29469760
[TBL] [Abstract][Full Text] [Related]
43. Spectrum of anticonvulsant hypersensitivity syndrome: controversy of treatment.
Lee WC; Leung JL; Fung CW; Chung BH; Wong V
J Child Neurol; 2004 Aug; 19(8):619-23. PubMed ID: 15605473
[TBL] [Abstract][Full Text] [Related]
44. Nonpigmenting fixed drug eruption as a possible abortive variant of toxic epidermal necrolysis: immunohistochemical and serum cytokine analyses.
Mizukawa Y; Shiohara T
Clin Exp Dermatol; 2010 Jul; 35(5):493-7. PubMed ID: 19874369
[TBL] [Abstract][Full Text] [Related]
45. Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
Finkelstein Y; Soon GS; Acuna P; George M; Pope E; Ito S; Shear NH; Koren G; Shannon MW; Garcia-Bournissen F
Pediatrics; 2011 Oct; 128(4):723-8. PubMed ID: 21890829
[TBL] [Abstract][Full Text] [Related]
46. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis.
Wolkenstein P; Latarjet J; Roujeau JC; Duguet C; Boudeau S; Vaillant L; Maignan M; Schuhmacher MH; Milpied B; Pilorget A; Bocquet H; Brun-Buisson C; Revuz J
Lancet; 1998 Nov; 352(9140):1586-9. PubMed ID: 9843104
[TBL] [Abstract][Full Text] [Related]
47. Human immunodeficiency virus, pregnancy, and Stevens-Johnson syndrome.
Shilad A; Predanic M; Perni SC; Houlihan C; Principe D
Obstet Gynecol; 2005 May; 105(5 Pt 2):1254-6. PubMed ID: 15863600
[TBL] [Abstract][Full Text] [Related]
48. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
[TBL] [Abstract][Full Text] [Related]
49. Variable levels of apoptotic signal-associated cytokines in the disease course of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Yang Y; Li F; Du J; Shen Y; Lin J; Zhu X; Luo X; Liang J; Xu J
Australas J Dermatol; 2017 Aug; 58(3):e61-e67. PubMed ID: 27040133
[TBL] [Abstract][Full Text] [Related]
50. Toxic epidermal necrolysis: 13 years of experience in the management at a Department of Dermatology in China.
Zhang F; Zhou J
Cutan Ocul Toxicol; 2017 Mar; 36(1):19-24. PubMed ID: 27079364
[TBL] [Abstract][Full Text] [Related]
51. Plasma activity of interleukin-6 and some acute phase proteins in severe drug-induced skin adverse reactions.
Czelej D; Chodorowska G; Lecewicz-Toruń B
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):62-7. PubMed ID: 12898820
[TBL] [Abstract][Full Text] [Related]
52. Minimal clinically important differences for measures of treatment efficacy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Kim WB; Worley B; Holmes J; Phillips EJ; Beecker J
J Am Acad Dermatol; 2018 Dec; 79(6):1150-1152. PubMed ID: 29890189
[No Abstract] [Full Text] [Related]
53. High-mobility group box 1 protein (HMGB1) as a novel diagnostic tool for toxic epidermal necrolysis and Stevens-Johnson syndrome.
Nakajima S; Watanabe H; Tohyama M; Sugita K; Iijima M; Hashimoto K; Tokura Y; Nishimura Y; Doi H; Tanioka M; Miyachi Y; Kabashima K
Arch Dermatol; 2011 Sep; 147(9):1110-2. PubMed ID: 21931056
[No Abstract] [Full Text] [Related]
54. Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis.
Correia O; Delgado L; Barbosa IL; Campilho F; Fleming-Torrinha J
J Am Acad Dermatol; 2002 Jul; 47(1):58-62. PubMed ID: 12077582
[TBL] [Abstract][Full Text] [Related]
55. Apoptosis in ibuprofen-induced Stevens-Johnson syndrome.
Neuman M; Nicar M
Transl Res; 2007 May; 149(5):254-9. PubMed ID: 17466924
[TBL] [Abstract][Full Text] [Related]
56. Corticosteroids in the treatment of skin disorders.
Wheeler CE; Briggaman RA; Puritz EM
Am Fam Physician; 1973 Jan; 7(1):130-40. PubMed ID: 4682971
[No Abstract] [Full Text] [Related]
57. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation.
Miki C; Gunson BK; Buckels JA; Uchida K; Mohri Y; Kusunoki M
Ann Surg; 2009 Sep; 250(3):502-3; author reply 503-4. PubMed ID: 19730189
[No Abstract] [Full Text] [Related]
58. Preoperative methylprednisolone administration maintains coagulation homeostasis in patients undergoing liver resection: importance of inflammatory cytokine modulation.
Pulitanò C; Aldrighetti L; Arru M; Finazzi R; Catena M; Guzzetti E; Soldini L; Comotti L; Ferla G
Shock; 2007 Oct; 28(4):401-5. PubMed ID: 17577134
[TBL] [Abstract][Full Text] [Related]
59. Differences in immunological alterations and underlying viral infections in two well-defined severe drug eruptions.
Hirahara K; Kano Y; Mitsuyama Y; Takahashi R; Kimishima M; Shiohara T
Clin Exp Dermatol; 2010 Dec; 35(8):863-8. PubMed ID: 20456395
[TBL] [Abstract][Full Text] [Related]
60. [Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lomé, Togo: retrospective study of 89 cases].
Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Tchangaï-Walla K; Pitché P
Med Trop (Mars); 2010 Jun; 70(3):255-8. PubMed ID: 20734593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
